» Articles » PMID: 17244710

Regulated Surface Expression and Shedding Support a Dual Role for Semaphorin 4D in Platelet Responses to Vascular Injury

Overview
Specialty Science
Date 2007 Jan 25
PMID 17244710
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Semaphorin 4D (sema4D; CD100) is an integral membrane protein and the ligand for two receptors, CD72 and plexin-B1. Soluble sema4D has been shown to evoke angiogenic responses from endothelial cells and impair monocyte migration, but the origin of soluble sema4D, particularly at sites of vascular injury, has been unclear. Here we show that platelets express sema4D and both of its receptors and provide evidence that these molecules promote thrombus formation. We also show that the surface expression of sema4D and CD72 increases during platelet activation, followed by the gradual shedding of the sema4D extracellular domain. Shedding is blocked by metalloprotease inhibitors and abolished in mouse platelets that lack the metalloprotease ADAM17 (TACE). Mice that lack sema4D exhibit delayed arterial occlusion after vascular injury in vivo, and their platelets show impaired collagen responses in vitro. In resting platelets, as in B lymphocytes, CD72 is associated with the protein tyrosine phosphatase SHP-1. Platelet activation causes dissociation of the complex, as does the addition of soluble sema4D. These findings suggest a dual role for sema4D in vascular responses to injury. As thrombus formation begins, platelet-associated sema4D can bind to its receptors on nearby platelets, promoting thrombus formation. As thrombus formation continues, sema4D is shed from the platelet surface and becomes available to interact with receptors on endothelial cells and monocytes, as well as continuing to interact with platelets.

Citing Articles

Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring.

Bessa P, Newman A, Yan K, Schaub T, Dannenberg R, Lajko D Nat Commun. 2024; 15(1):7059.

PMID: 39152101 PMC: 11329519. DOI: 10.1038/s41467-024-51009-1.


Soluble Semaphorin 4D Serum Concentrations Are Elevated in Critically Ill Patients with Liver Cirrhosis and Correlate with Aminotransferases.

Abu Jhaisha S, Hohlstein P, Yagmur E, Koller V, Pollmanns M, Adams J Diagnostics (Basel). 2024; 14(4).

PMID: 38396409 PMC: 10887520. DOI: 10.3390/diagnostics14040370.


SEMA4D/VEGF surface enhances endothelialization by diminished-glycolysis-mediated M2-like macrophage polarization.

Cui Y, Jiang X, Yang M, Yuan Y, Zhou Z, Gao X Mater Today Bio. 2023; 23:100832.

PMID: 38024840 PMC: 10630656. DOI: 10.1016/j.mtbio.2023.100832.


New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins.

Jacob T, Doshi G Endocr Metab Immune Disord Drug Targets. 2023; 24(8):865-878.

PMID: 37605412 DOI: 10.2174/1871530323666230821102718.


Platelet formation and activation are influenced by neuronal guidance proteins.

Tang L, Liu C, Rosenberger P Front Immunol. 2023; 14:1206906.

PMID: 37398659 PMC: 10310924. DOI: 10.3389/fimmu.2023.1206906.


References
1.
Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T . The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity. 2000; 13(5):633-42. DOI: 10.1016/s1074-7613(00)00063-7. View

2.
Basile J, Castilho R, Williams V, Gutkind J . Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A. 2006; 103(24):9017-22. PMC: 1482558. DOI: 10.1073/pnas.0508825103. View

3.
Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A . Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol. 2001; 166(7):4348-54. DOI: 10.4049/jimmunol.166.7.4348. View

4.
Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H . Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood. 2001; 97(11):3498-504. DOI: 10.1182/blood.v97.11.3498. View

5.
Kumanogoh A, Kikutani H . The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol. 2001; 22(12):670-6. DOI: 10.1016/s1471-4906(01)02087-7. View